{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Until last February, Mary Ellen Geist was the archetypal career woman, a radio news anchor with a six-figure salary and a suitcase always packed for the next adventure, whether a third-world coup, a weekend of wine tasting or a job in a bigger market. But now, Ms. Geist, 49, has a life that would be unrecognizable to colleagues and friends in Los Angeles, San Francisco and New York City. She has returned to her family home near Detroit to care for her parents, one lost to dementia and the other to sorrow.", "headline": {"main": "Forget the Career. My Parents Need Me at Home."}, "abstract": null, "print_page": "1", "word_count": 2010, "_id": "4fd269308eb7c8105d81f739", "snippet": "Mary Ellen Geist used to be the archetypal career woman. She is now caring for her parents, one lost to dementia and the other to sorrow.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/24/national/24daughter.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "FAMILIES AND FAMILY LIFE"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Jane", "rank": 1, "lastname": "GROSS"}], "original": "By JANE GROSS"}, "document_type": "article", "pub_date": "2005-11-24T00:00:00Z", "section_name": "Front Page; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Decisions, decisions. The clock is ticking for millions of elderly and disabled people, who must decide whether and when to enroll in one of the new Medicare Part D drug plans that start Jan. 1, 2006. The Part D program, named for its place within the written Medicare law, for the first time brings drugs under the Medicare tent, which covers 42 million people. It has been widely portrayed as hopelessly confusing.", "headline": {"main": "The Drug Decision; Millions Face a Deadline for Choosing a New Medicare Plan"}, "abstract": null, "print_page": "1", "word_count": 1683, "_id": "4fd251138eb7c8105d7f55fe", "snippet": "Before you throw up your hands, there are basic steps that can be taken to help decide which plan is right for you.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/24/business/24drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "DEPARTMENT OF VETERANS AFFAIRS"}, {"name": "organizations", "value": "CONGRESS"}, {"name": "organizations", "value": "HUMANA INCORPORATED"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS"}, {"name": "subject", "value": "INSURANCE"}, {"name": "subject", "value": "DRUGSTORES"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "MEDICARE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "COMPUTERS AND THE INTERNET"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Milt", "rank": 1, "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2005-11-24T00:00:00Z", "section_name": "Technology; Health; Business"}, {"type_of_material": "Series", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "Penlac Nail Lacquer rarely cures the nail fungus it is designed to treat, yet it costs $130 a thimbleful. As a result, more than 20 state Medicaid programs and dozens of private health insurers require doctors to get advance permission to prescribe it. But not New York Medicaid, which spent $12 million on the drug last year, more than eight times as much as any other state. New York spent $74 million last year, far more than any other state, on Nexium, the ''new Purple Pill'' for heartburn. The drug is virtually identical to Prilosec, available at one-sixth the cost over the counter, and so at least 20 state Medicaid programs and many private health insurance companies severely restrict its use. Only now, two years after other states began imposing limits on Nexium, has New York moved to restrict it.", "headline": {"main": "Drug Costs Run Free Under New York Medicaid", "kicker": "Program Disorder"}, "abstract": "New York Medicaid allows doctors to prescribe drugs that are restricted in many other states and is less aggressive in setting prices paid to pharmacies for drugs they dispense; result is that New York Medicaid spends more on drugs for each Medicaid recipient than any other state but West Virginia; New York Medicaid spending on prescription drugs more than doubled in five years, to $3.8 billion in 2004, helping to make state's Medicaid program, at $44.5 billion, by far the largest and most generous in country; cost can be traced in part to years of industry lobbying in Albany; even bill adopted this spring to adopt one of most basic cost controls, preferred drug list, has unusual loophole that would allow doctors to easily circumvent it; graph of spending on Penlac Nail Lacquer and Nexium, which illustrate New York's loose controls; graphs on Medicaid drug spending by state; photos (L)", "print_page": "1", "word_count": 2954, "_id": "4fd262f98eb7c8105d814d51", "snippet": "Lacking the most basic controls, New York frequently pays many times more for drugs than Medicaid programs in other states.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/23/nyregion/23medicaid.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "NEW YORK STATE"}, {"name": "organizations", "value": "SANOFI-AVENTIS"}, {"name": "organizations", "value": "ASTRAZENECA PLC"}, {"name": "subject", "value": "PENLAC NAIL LACQUER"}, {"name": "subject", "value": "NEXIUM (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Michael", "rank": 1, "lastname": "LUO"}], "original": "By MICHAEL LUO; Clifford J. Levy and Tom Torok contributed reporting for this article"}, "document_type": "article", "pub_date": "2005-11-23T00:00:00Z", "section_name": "Front Page; Health; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Foreign Desk", "lead_paragraph": "At long last, two months after one of the strangest elections in Germany's modern history, Parliament seems certain on Tuesday to elect Angela Merkel, the leader of the conservative Christian Democratic Party, as chancellor, the first woman to hold the position. Mrs. Merkel will immediately take power, name a cabinet and actually start governing, after weeks of intense negotiations over a program to pursue a ''grand coalition'' with her chief rivals, the Social Democrats of the departing Chancellor Gerhard Schr\u00f6der.", "headline": {"main": "Germany Passes Torch to New Generation"}, "abstract": "German parliament will elect Angela Merkel as first woman chancellor after two months of post-election negotiating to create 'grand coalition' between her conservative Christian Democrats and Social Democrats of Chancellor Gerhard Schroder; her ascent marks shift to new political generation, also seen in election of Matthias Platzeck, also from east, to lead Social Democratic party (M)", "print_page": "3", "word_count": 928, "_id": "4fd24e238eb7c8105d7ef774", "snippet": "Not only is Angela Merkel the first woman to become chancellor, but her ascent signals a shift to a new political generation.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/22/international/europe/22germany.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "MERKEL, ANGELA"}, {"name": "persons", "value": "SCHRODER, GERHARD"}, {"name": "persons", "value": "PLATZECK, MATTHIAS"}, {"name": "glocations", "value": "GERMANY"}, {"name": "subject", "value": "POLITICS AND GOVERNMENT"}, {"name": "subject", "value": "ELECTIONS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Richard", "rank": 1, "lastname": "BERNSTEIN"}], "original": "By RICHARD BERNSTEIN"}, "document_type": "article", "pub_date": "2005-11-22T00:00:00Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "More than 10 million people in the United States are cancer survivors, and their numbers increase daily. Many are considered cured. Some are still in treatment and one day may -- or may not -- be counted among the cured. Others are living with advanced disease. But nearly all have similar needs: A need to know about and cope with the physical and emotional consequences of cancer and its treatment, including current challenges to quality of life and delayed health effects.", "headline": {"main": "With Cancer, Treatment Is Only Part of the Picture", "kicker": "PERSONAL HEALTH"}, "abstract": "Jane E Brody Personal Health column discusses what cancer survivors should do after initial treatment for cancer has been completed; Dr Sheldon Greenfield, University of California, Irvine, Center for Health Policy Research director, leads study sanctioned by National Academies to develop survivorship care plan; more than 10 million Americans are cancer survivors; drawing (M)", "print_page": "8", "word_count": 1158, "_id": "4fd24e238eb7c8105d7ef769", "snippet": "More than 10 million people in the United States are cancer survivors, and their numbers increase daily. Many are considered cured. Some are still in treatment and one day may -- or may not -- be counted among the cured. Others are living with...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9907E4DB1F3EF931A15752C1A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "PERSONAL HEALTH (TIMES COLUMN)"}, {"name": "persons", "value": "GREENFIELD, SHELDON"}, {"name": "organizations", "value": "NATIONAL ACADEMIES OF THE UNITED STATES"}, {"name": "organizations", "value": "UNIVERSITY OF CALIFORNIA"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "Brody", "rank": 1, "role": "reported", "organization": ""}], "original": "By Jane E. Brody"}, "document_type": "article", "pub_date": "2005-11-22T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 15, "offset": 10, "time": 197}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}